BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Ginkgo Bioworks

Ginkgo Bioworks logo

Website
http://ginkgobioworks.com/
Founded
2009

Ginkgo Bioworks designs, engineers, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals.

Gingko Bioworks also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Tom Knight, Reshama Shetty, Jason Kelly, Barry Canton, and Austin Che founded Ginkgo Bioworks in 2009. Its headquarters in Boston in Massachusetts.


Articles Mentioning This Company

AI in Synthetic Biology: From Gene Editing to Pathway Design

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

Oct. 22, 2025     Articles
Synthetic biology refers to the purposeful design and construction of new biological components, devices, and systems, as well as the re-engineering of existing natural biological systems to serve practical functions. It extends the principles of genetic engineering, adopting a design-driven approach that incorporates concepts such as standardization, modularity and abstraction. …

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

Sept. 30, 2025     Business Intelligence
Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation models are a class of large-scale machine learning models, typically based on deep learning architectures such as transformers, that are trained on massive datasets encompassing diverse types of data. The …

Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering

April 26, 2024     Interviews
The integration of artificial intelligence (AI) in biotech is not just enhancing the efficiency of processes but is also enabling the discovery of novel biological insights that were once beyond reach. As the industry seeks to meet the increasing demand for protein-based products across various sectors, including pharmaceuticals, agriculture, and …

News

  • 2026-05-26
    Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One, a Packaged ADME Service for Early Discovery
  • 2025-11-20
    Ginkgo Bioworks Launches Open-Source Pharmacology Framework for AI Drug Discovery
  • 2024-02-28
    A Busy Day for Ginkgo Bioworks

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.